Berlin

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• ALS (motor neurone disease)1 trial
• COPD1 trial
• Head and neck cancer1 trial
• Melanoma1 trial

Phase

• Phase 22 trials
• Phase 1/21 trial
• Phase 31 trial

Status

• Terminated3 trials
• Recruiting1 trial

Lead sponsor

• Sanofi4 trials

Running trials

• Recruiting

  Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

  NCT07190222· Phase 3· Sanofi· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• COPD1 recruiting

Closed trials

• Terminated

  Phase 2 Study for SAR443820 in Participants With Amyotrophic Lateral Sclerosis (ALS)

  NCT05237284· Phase 2· Sanofi· Source

• Terminated

  A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With HNSCC (Master Protocol) (Pegathor Head and Neck 204)

  NCT05061420· Phase 2· Sanofi· Source

• Terminated

  A Study of SAR444245 Combined With Cemiplimab for the Treatment of Participants With Various Advanced Skin Cancers (Pegathor Skin 201)

  NCT04913220· Phase 1/2· Sanofi· Source